On October 30th, cansino biologics inc. stocks rose together, with A-shares rising by over 7% to 59.9 yuan at one point, and H-shares rising by over 14% to 30 Hong Kong dollars at one point. The group announced that, according to Chinese Accounting Standards, the net income attributable to shareholders in the third quarter was 2.96 million yuan, turning losses into profits on a year-on-year basis; revenue increased by 76% year-on-year to 0.264 billion yuan. (Gelonghui)
港A异动丨康希诺A股涨超7%，H股涨超14%，Q3收入同比大增76%
Hong Kong-listed cansino biologics inc. A-shares rose more than 7%, H-shares rose more than 14%, Q3 revenue increased by 76% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated